Literature DB >> 21762728

Cross-talk between the complement and the kinin system in vascular permeability.

Fleur Bossi1, Ellinor I Peerschke, Berhane Ghebrehiwet, Francesco Tedesco.   

Abstract

The endothelium is a continuous physical barrier that regulates coagulation and selective passage of soluble molecules and circulating cells through the vessel wall into the tissue. Due to its anatomic localization, the endothelium may establish contact with components of the complement, the kinin and the coagulation systems which are the main, though not exclusive, inducers of vascular leakage. Although the complement and the kinin systems may act independently, increasing evidence suggest that there is a crosstalk that involve different components of both systems. Activation is required for the function of the two systems which are involved in pathological conditions such as hereditary and acquired angioedema (AE) and vasculitidis. The aim of this review is to discuss the contribution of complement and kinin systems to vascular leakage and the cross-talk between the two systems in the development of AE. This clinical condition is characterized by episodic and recurrent local edema of subcutaneous and submucosal tissues and is due to inherited or acquired C1-INH deficiency. Although the pathogenesis of the swelling in patients with AE was originally thought to be mediated by C2, ample evidence indicate bradykinin (BK) as the most effective mediator even though the possibility that both the complement and the kinin-forming systems may contribute to the edema has not been completely excluded. BK induces endothelial leakage interacting with B2 receptors but other molecules may be involved in the onset and maintenance of AE. In this review we shall discuss the role of B1 receptors and gC1qR/p33 in addition to that of B2 receptors in the onset of AE attacks and the importance of these receptors as new possible molecular targets for therapy.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21762728      PMCID: PMC3162365          DOI: 10.1016/j.imlet.2011.06.006

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  68 in total

1.  Expression of receptors for complement anaphylatoxins C3a and C5a following permanent focal cerebral ischemia in the mouse.

Authors:  J Van Beek; M Bernaudin; E Petit; P Gasque; A Nouvelot; E T MacKenzie; M Fontaine
Journal:  Exp Neurol       Date:  2000-01       Impact factor: 5.330

Review 2.  Kallikrein-kinin in infection and cancer.

Authors:  H Maeda; J Wu; T Okamoto; K Maruo; T Akaike
Journal:  Immunopharmacology       Date:  1999-09

3.  The first subcomponent of complement, C1q, triggers the production of IL-8, IL-6, and monocyte chemoattractant peptide-1 by human umbilical vein endothelial cells.

Authors:  R H van den Berg; M C Faber-Krol; R B Sim; M R Daha
Journal:  J Immunol       Date:  1998-12-15       Impact factor: 5.422

Review 4.  Tissue kallikreins structure, regulation, and participation in mammalian physiology and disease.

Authors:  H S Margolius
Journal:  Clin Rev Allergy Immunol       Date:  1998       Impact factor: 8.667

5.  Control of the classical and the MBL pathway of complement activation.

Authors:  S V Petersen; S Thiel; L Jensen; T Vorup-Jensen; C Koch; J C Jensenius
Journal:  Mol Immunol       Date:  2000-10       Impact factor: 4.407

6.  Complement activation after oxidative stress: role of the lectin complement pathway.

Authors:  C D Collard; A Väkevä; M A Morrissey; A Agah; S A Rollins; W R Reenstra; J A Buras; S Meri; G L Stahl
Journal:  Am J Pathol       Date:  2000-05       Impact factor: 4.307

7.  Plasma bradykinin in angio-oedema.

Authors:  J Nussberger; M Cugno; C Amstutz; M Cicardi; A Pellacani; A Agostoni
Journal:  Lancet       Date:  1998-06-06       Impact factor: 79.321

8.  The endothelium is an extrahepatic site of synthesis of the seventh component of the complement system.

Authors:  H Langeggen; M Pausa; E Johnson; C Casarsa; F Tedesco
Journal:  Clin Exp Immunol       Date:  2000-07       Impact factor: 4.330

9.  Cytokeratin 1 and gC1qR mediate high molecular weight kininogen binding to endothelial cells.

Authors:  K Joseph; B Ghebrehiwet; A P Kaplan
Journal:  Clin Immunol       Date:  1999-09       Impact factor: 3.969

Review 10.  Extrahepatic synthesis of complement proteins in inflammation.

Authors:  J Laufer; Y Katz; J H Passwell
Journal:  Mol Immunol       Date:  2001-08       Impact factor: 4.407

View more
  21 in total

1.  Knockdown of circulating C1 inhibitor induces neurovascular impairment, glial cell activation, neuroinflammation, and behavioral deficits.

Authors:  Dorit Farfara; Emily Feierman; Allison Richards; Alexey S Revenko; Robert A MacLeod; Erin H Norris; Sidney Strickland
Journal:  Glia       Date:  2019-03-18       Impact factor: 7.452

Review 2.  Inflammation, immunosuppressive microenvironment and breast cancer: opportunities for cancer prevention and therapy.

Authors:  Sachin Kumar Deshmukh; Sanjeev Kumar Srivastava; Teja Poosarla; Donna Lynn Dyess; Nicolette Paolaungthong Holliday; Ajay Pratap Singh; Seema Singh
Journal:  Ann Transl Med       Date:  2019-10

3.  The non-inflammatory role of C1q during Her2/neu-driven mammary carcinogenesis.

Authors:  Silvio Bandini; Marco Macagno; Albana Hysi; Stefania Lanzardo; Laura Conti; Amanda Bello; Federica Riccardo; Roberto Ruiu; Irene Fiore Merighi; Guido Forni; Manuela Iezzi; Elena Quaglino; Federica Cavallo
Journal:  Oncoimmunology       Date:  2016-11-08       Impact factor: 8.110

4.  Disease-modifying factors in hereditary angioedema: an RNA expression-based screening.

Authors:  Alberto López-Lera; Fátima Sánchez Cabo; Sofía Garrido; Ana Dopazo; Margarita López-Trascasa
Journal:  Orphanet J Rare Dis       Date:  2013-05-20       Impact factor: 4.123

Review 5.  Complement system in dermatological diseases - fire under the skin.

Authors:  Jaana Panelius; Seppo Meri
Journal:  Front Med (Lausanne)       Date:  2015-01-29

6.  Endothelial transmigration by Trypanosoma cruzi.

Authors:  Bria M Coates; David P Sullivan; Ming Y Makanji; Nga Y Du; Cheryl L Olson; William A Muller; David M Engman; Conrad L Epting
Journal:  PLoS One       Date:  2013-12-02       Impact factor: 3.240

Review 7.  Versatility of the complement system in neuroinflammation, neurodegeneration and brain homeostasis.

Authors:  Franca Orsini; Daiana De Blasio; Rosalia Zangari; Elisa R Zanier; Maria-Grazia De Simoni
Journal:  Front Cell Neurosci       Date:  2014-11-07       Impact factor: 5.505

8.  Exploring the human plasma proteome for humoral mediators of remote ischemic preconditioning--a word of caution.

Authors:  Erik Helgeland; Lars Ertesvåg Breivik; Marc Vaudel; Øyvind Sverre Svendsen; Hilde Garberg; Jan Erik Nordrehaug; Frode Steingrimsen Berven; Anne Kristine Jonassen
Journal:  PLoS One       Date:  2014-10-15       Impact factor: 3.240

Review 9.  Inflammation and thrombosis in COVID-19 pathophysiology: proteinase-activated and purinergic receptors as drivers and candidate therapeutic targets.

Authors:  Krishna Sriram; Paul A Insel
Journal:  Physiol Rev       Date:  2020-10-30       Impact factor: 37.312

10.  Adeno-associated virus mediated delivery of a non-membrane targeted human soluble CD59 attenuates some aspects of diabetic retinopathy in mice.

Authors:  Mehreen Adhi; Siobhan M Cashman; Rajendra Kumar-Singh
Journal:  PLoS One       Date:  2013-10-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.